EAM Investors’s PharMerica Corporation PMC Stock Holding History

EAM Investors’s Portfolio PMC Stock Details PMC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-23,595	Closed	-$672K	–	389
2015 Q3	$672K	Buy	+23,595	New	+$793K	0.11%	286
2014 Q4	–	Sell	-33,502	Closed	-$818K	–	404
2014 Q3	$818K	Sell	33,502 -5,635	-14%	-$149K	0.17%	289
2014 Q2	$1.12M	Buy	+39,137	New	+$1.09M	0.21%	268

Other funds holding PMC

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

CCM

Century Capital Management Boston, Massachusetts $581M AUM 29.61% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return

EAM Investors's PMC Position: Q4 2015 in Review

EAM Investors sold out of PharMerica Corporation (PMC) in Q4 2015, closing a stake of 23,595 shares — an estimated $672K sold.

EAM Investors first reported a position in PMC in Q2 2014 and held it in 3 quarters. The position peaked at $1.12M in Q2 2014. 195 funds tracked by Wall St. Rank hold PMC as of Q4 2015.

EAM Investors reported no remaining PharMerica Corporation position as of Q4 2015 after selling out during the quarter.
EAM Investors sold 23,595 PharMerica Corporation shares in Q4 2015, an estimated $672K.
EAM Investors first reported a position in PharMerica Corporation in Q2 2014 and held it in 3 quarters.
EAM Investors's PharMerica Corporation position peaked at $1.12M in Q2 2014.
195 funds tracked by Wall St. Rank held PharMerica Corporation as of Q4 2015.

Based on EAM Investors's 13F filing for Q4 2015, filed 5 Feb 2016.